New research reveals how cannabis compound could slow tumour growth
Scientists at the University of East Anglia have shown how the main psychoactive ingredient in cannabis could reduce tumor growth in cancer patients.
Jul 14, 2014
0
1
Scientists at the University of East Anglia have shown how the main psychoactive ingredient in cannabis could reduce tumor growth in cancer patients.
Jul 14, 2014
0
1
An international group led by Vanderbilt University researchers has found cannabinoid receptors, through which marijuana exerts its effects, in a key emotional hub in the brain involved in regulating anxiety and the flight-or-fight ...
Mar 6, 2014
0
1
(Medical Xpress)—Chemical compounds found in cannabis may help to reduce brain damage following a stroke, new research has revealed.
Dec 3, 2013
0
0
New research has shown that the non-hallucinogenic components of cannabis could act as effective anti-cancer agents.
Oct 14, 2013
0
0
Insufficient sleep may contribute to weight gain and obesity by raising levels of a substance in the body that is a natural appetite stimulant, a new study finds. The results were presented today at The Endocrine Society's ...
Jun 17, 2013
0
0
In a first-of-its-kind effort to illuminate the biochemical impact of trauma, researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known ...
May 14, 2013
0
0
Researchers at the University of the Basque Country (UPV/EHU) and the Achucarro neurosciences centre have discovered a new therapy for the fragile X chromosome syndrome. This new therapy proposes the modulation of the cerebral ...
Apr 10, 2013
0
0
(HealthDay)—U.S emergency rooms tended to more than 11,400 cases of drug-related health complications specifically linked to the use of synthetic marijuana in 2010, a new government report reveals.
Dec 4, 2012
1
0
Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent ...
Nov 1, 2012
0
0
A study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic ...
Oct 30, 2012
0
0